BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 24302750)

  • 21. Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer.
    Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; Kerkhofs T; Williams AR; Ardito A; Leboulleux S; Volante M; Deutschbein T; Feelders R; Ronchi C; Grisanti S; Gelderblom H; Porpiglia F; Papotti M; Hammer GD; Allolio B; Terzolo M
    Eur Urol; 2014 Apr; 65(4):832-8. PubMed ID: 24268504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma.
    Megerle F; Herrmann W; Schloetelburg W; Ronchi CL; Pulzer A; Quinkler M; Beuschlein F; Hahner S; Kroiss M; Fassnacht M;
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1686-1695. PubMed ID: 29452402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm.
    Abdel-Aziz TE; Rajeev P; Sadler G; Weaver A; Mihai R
    World J Surg; 2015 May; 39(5):1268-73. PubMed ID: 25526921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis, treatment, and survival analysis of adrenocortical carcinomas: a multicentric study.
    Souteiro P; Donato S; Costa C; Pereira CA; Simões-Pereira J; Oliveira J; Belo S; Santos AP; Cardoso H; Leite V; Carvalho D; Torres I
    Hormones (Athens); 2020 Jun; 19(2):197-203. PubMed ID: 31823340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma.
    Gharzai LA; Green MD; Griffith KA; Else T; Mayo CS; Hesseltine E; Spratt DE; Ben-Josef E; Sabolch A; Miller BS; Worden F; Giordano TJ; Hammer GD; Jolly S
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3743-3750. PubMed ID: 31220287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenocortical carcinoma: Retrospective analysis of the last 22 years.
    Guelho D; Paiva I; Vieira A; Carrilho F
    Endocrinol Nutr; 2016 May; 63(5):212-9. PubMed ID: 26969077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of Mitotane and Locoregional Treatments in Low-volume Metastatic Adrenocortical Carcinoma.
    Boilève A; Mathy E; Roux C; Faron M; Hadoux J; Tselikas L; Al Ghuzlan A; Hescot S; Leboulleux S; de Baere T; Lamartina L; Deschamps F; Baudin E
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4698-e4707. PubMed ID: 34143888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach.
    Donatini G; Caiazzo R; Do Cao C; Aubert S; Zerrweck C; El-Kathib Z; Gauthier T; Leteurtre E; Wemeau JL; Vantyghem MC; Carnaille B; Pattou F
    Ann Surg Oncol; 2014 Jan; 21(1):284-91. PubMed ID: 24046101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disparate Practice Patterns and Survival Outcomes: The Impact of Centralization of Cancer Care for Adrenocortical Carcinoma in the United States.
    Stone BV; Tallman JE; Moses KA
    J Urol; 2021 Oct; 206(4):866-872. PubMed ID: 34032493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection.
    Terzolo M; Baudin AE; Ardito A; Kroiss M; Leboulleux S; Daffara F; Perotti P; Feelders RA; deVries JH; Zaggia B; De Francia S; Volante M; Haak HR; Allolio B; Al Ghuzlan A; Fassnacht M; Berruti A
    Eur J Endocrinol; 2013 Sep; 169(3):263-70. PubMed ID: 23704714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
    Kwok GTY; Zhao JT; Glover AR; Gill AJ; Clifton-Bligh R; Robinson BG; Ip JCY; Sidhu SB
    Oncologist; 2019 Jun; 24(6):e241-e250. PubMed ID: 30918109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive treatment of adrenocortical carcinoma.
    Terzolo M; Berruti A
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):221-6. PubMed ID: 18438168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical management of adrenocortical carcinoma.
    Ranvier GG; Inabnet WB
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):435-52. PubMed ID: 26038210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study.
    Simon G; Pattou F; Mirallié E; Lifante JC; Nominé C; Arnault V; de Calan L; Caillard C; Carnaille B; Brunaud L; Laplace N; Caiazzo R; Blanchard C
    Surgery; 2017 Jan; 161(1):249-256. PubMed ID: 27855966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study.
    Elhassan YS; Altieri B; Berhane S; Cosentini D; Calabrese A; Haissaguerre M; Kastelan D; Fragoso MCBV; Bertherat J; Al Ghuzlan A; Haak H; Boudina M; Canu L; Loli P; Sherlock M; Kimpel O; Laganà M; Sitch AJ; Kroiss M; Arlt W; Terzolo M; Berruti A; Deeks JJ; Libé R; Fassnacht M; Ronchi CL
    Eur J Endocrinol; 2021 Nov; 186(1):25-36. PubMed ID: 34709200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.
    Ayala-Ramirez M; Jasim S; Feng L; Ejaz S; Deniz F; Busaidy N; Waguespack SG; Naing A; Sircar K; Wood CG; Pagliaro L; Jimenez C; Vassilopoulou-Sellin R; Habra MA
    Eur J Endocrinol; 2013 Dec; 169(6):891-899. PubMed ID: 24086089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcutaneous biopsy of adrenocortical carcinoma is rarely helpful in diagnosis, potentially harmful, but does not affect patient outcome.
    Williams AR; Hammer GD; Else T
    Eur J Endocrinol; 2014 Jun; 170(6):829-35. PubMed ID: 24836548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal patterns of recurrence in patients with adrenocortical carcinoma.
    Glenn JA; Else T; Hughes DT; Cohen MS; Jolly S; Giordano TJ; Worden FP; Gauger PG; Hammer GD; Miller BS
    Surgery; 2019 Jan; 165(1):186-195. PubMed ID: 30343951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane.
    Wängberg B; Khorram-Manesh A; Jansson S; Nilsson B; Nilsson O; Jakobsson CE; Lindstedt S; Odén A; Ahlman H
    Endocr Relat Cancer; 2010 Mar; 17(1):265-72. PubMed ID: 20026647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant and definitive radiotherapy for adrenocortical carcinoma.
    Sabolch A; Feng M; Griffith K; Hammer G; Doherty G; Ben-Josef E
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1477-84. PubMed ID: 20675074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.